Breast Cancer Risk Reduction: Current Status and Emerging Trends to Increase Efficacy and Reduce Toxicity of Preventive Medication Individualizing Breast Cancer Risk Assessment in Clinical Practice How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ Is Axillary Staging Obsolete in Early Breast Cancer? Evidence-Based Strategies to Minimize the Likelihood of Axillary Lymph Node Dissection in Clinically Node-Positive Patients Following Neoadjuvant Chemotherapy Managing the Morbidity: Individualizing Risk Assessment, Diagnosis, and Treatment Options for Upper Extremity Lymphedema Incorporating Tumor Biology to Select Patients for the Omission of Radiation Therapy Selecting Triple Negative Breast Cancer Patients for Immunotherapy Fertility and Sexual Health in Young Women with Early-Stage Breast Cancer Prepectoral Versus Subpectoral Implant-Based Reconstruction: How Do We Choose? Incorporating Value-Based Decisions in Breast Cancer Treatment Algorithms Addressing Inequalities in Breast Cancer Care Delivery Lasting Impacts of the COVID-19 Pandemic on Breast Cancer Diagnosis and Treatment in the United States.